Serum testosterone and cardiometabolic risk in Nigerian men with type 2 diabetes: a cross−sectional study

• by Ezekiel Musa, Esteban Salazar-Petres, Glory Chinuru Musa, Fatima Bello, Adamu Girei Bakari

• June 16, 2026

Association between leptin gene polymorphisms and hematological metabolic parameters in obese Saudi adults

• by Lamiaa Hamad Al-Jamea, Alexander Woodman, Rehab Yusuf Al-Ansari, Fatimah Salem Alayidh, Khalid Khalaf Alharbi, Nayef Saleh Al Ahmadi, Rashid Al-Jawair, Ibrahim Sahin, Shouq Saleh AlGhamdi, Emad Johar Al Johar, Jenifer Vecina Quiambao, Abdel Halim Deifalla, Yousef Mohammed Hawsawi

• June 5, 2026

Oral HRS-7535 Lowered A1c in Trial

Nonpeptide oral agent requires no fasting administration.

• by Kathryn Wighton

• June 5, 2026

• 9 min

Combo Therapy May Improve HbA1c in Type 2 Diabetes

Oral orforglipron could be more effective in reducing hemoglobin A1c and body weight, with no increased risk of hypoglycemia in patients with inadequately controlled type 2 diabetes.

• by Andrea Surnit

• June 12, 2026

• 4 min